Condition
Facet Joints; Degeneration
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05909709Phase 1RecruitingPrimary
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
NCT01788410RecruitingPrimary
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
NCT03871192Not ApplicableUnknown
Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome
Showing all 3 trials